Ronald Tong

Researchers sought to assess the safety and efficacy of ravulizumab for adults with amyotrophic lateral sclerosis.

Researchers conducted a phase 2 trial to assess the safety and efficacy of single-dose psilocybin treatment for major depressive disorder.

An eye-tracking test has identified a potential performance-based biomarker for the early diagnosis of autism spectrum disorder (ASD).

Researchers sought to investigate the effect of DOACs, compared with warfarin, on risk for dementia in patients with atrial fibrillation.

Researchers sought to investigate the association between psychosocial stressors and AF in postmenopausal women.

Researchers aimed to assess the safety and efficacy of Ginkgo diterpene lactone meglumine treatment in patients with acute ischemic stroke.

Blood tests for Alzheimer disease may improve diagnostic accuracy and treatment options.

In a phase 3 clinical trial, researchers are assessing the safety and efficacy of fosgonimeton with a randomized treatment duration of 26 weeks for mild to moderate Alzheimer disease.

Anuncia Medical Inc. has successfully launched the FDA-cleared ReFlow™ Mini Flusher for patients with hydrocephalus.

New clinical practice guidelines outline specific therapeutic exercises to treat migraine symptoms.